重视FIGO Ⅰ期卵巢恶性肿瘤术中肿瘤破裂对预后的不利影响  被引量:3

Attention to the Adverse Effect of Intraoperative Capsule Rupture on Prognosis for Women with FIGO Stage Ⅰ Ovarian Malignancy

在线阅读下载全文

作  者:王登凤[1] 张国楠[1] Wang Dengfeng;Zhang Guonan(Department of Gynecologic Oncology,Sichuan Clinical Research Center for Cancer,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,Affiliated Cancer Hospital of University of Electronic Science and Technology of China,Chendu 610041,Sichuan,China)

机构地区:[1]四川省肿瘤临床医学研究中心,四川省肿瘤医院·研究所,四川省癌症防治中心,电子科技大学附属肿瘤医院妇瘤科,成都610041

出  处:《肿瘤预防与治疗》2023年第3期183-187,共5页Journal of Cancer Control And Treatment

摘  要:卵巢恶性肿瘤是复发率和病死率最高的妇科常见恶性肿瘤。手术是早期患者的首选治疗手段,预后较好。但随着腹腔镜手术越来越普及,术中肿瘤破裂的发生率逐渐升高。虽然开腹手术和腹腔镜手术中的肿瘤破裂都会对患者预后产生不良影响,但腹腔镜手术的肿瘤破裂风险更高,而术后辅助化疗不一定能起到补救性作用。对于预后较好的FIGO Ⅰ期卵巢恶性肿瘤,我们更应该重视这一问题,通过充分的术前评估、严格掌握腹腔镜适应证、规范的无瘤操作,避免术中肿瘤破裂导致的医源性分期上升及其给患者带来的不可逆影响。Ovarian malignancy is a common gynecological malignant tumor with the highest recurrence rate and mortality.Surgery is the preferred treatment for early stage patients,leading to a good prognosis.However,with the increasing popularity of laparoscopic surgery,the incidence of intraoperative capsule rupture is gradually increasing.Although intraoperative capsule rupture in either laparotomy or laparoscopic surgery may have adverse effect on the prognosis,there is a higher risk of intraoperative capsule rupture in laparoscopic surgery,and postoperative adjuvant chemotherapy may not play a remedial role.For FIGO stage Ⅰ ovarian malignancy patients with a good prognosis,we should pay more attention to this issue,and avoid rise in iatrogenic stage caused by intraoperative capsule rupture and its irreversible impact on patients through adequate preoperative evaluation,strict mastery of laparoscopic indications,and standardized tumor-free surgery.

关 键 词:卵巢恶性肿瘤 术中肿瘤破裂 预后 化疗 无瘤原则 

分 类 号:R737.31[医药卫生—肿瘤] R730.56[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象